XTLB: XTL Biopharmaceuticals Ltd Kompaniya qiymatining sof foydaga nisbati
Quyida -5.60 indikatori bilan ko'rsatilgan XTL Biopharmaceuticals (XTLB) narx trayektoriyasi immun dori ishlab chiquvchi kompaniyaga tegishli. XTL Biopharmaceuticals (XTLB) tajriba yo'qotilishining oldini oluvchi olimlarning barqaror yadrosiga tayanadi. Rivojlanish vektori yangi aktivlarni sotib olish orqali dori portfelini kengaytirishga qaratilgan. Biroq, moliyaviy barqarorlik investitsiya talablari va tizimli qizil toshli bo'g'imlar (lupus) davolash bo'yicha klinik sinovlarning muvaffaqiyatsiz tugash ehtimoli bilan cheklangan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_XTLB_-_XTL-Biopharmaceuticals_-_PE-Multiple "XTLB: XTL Biopharmaceuticals Biznesning o‘zini qoplash muddati 02.04.2023 - 31.03.2026 | 👁️GURU.Markets👁️")
XTL Biopharmaceuticals, Ltd. (XTLB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati XTL Bio|XTLB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati XTL Biopharmaceuticals Ltd.|XTLB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz XTL Biopharmaceuticals|Shoshilinch likvidlik koeffitsiyenti xtlbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
XTLB - Sof daromad|Kelajakdagi sof foyda XTL Biopharmaceuticals|XTLB - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati XTL Biopharmaceuticals Ltd|XTLB - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati XTL Biopharmaceuticals Ltd.|XTLB - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda XTL Biopharmaceuticals|XTLB - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi xtlbio.com|XTLB - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi XTL Biopharmaceuticals
Kompaniyaning har tomonlama tahlili:xtlbio.com XTLB
Autoimmun patologiyalar terapiyasi ishlab chiquvchisi XTL Biopharmaceuticals (XTLB) uchun investitsiyaviy jozibadorlik klinik sinovlarning uzoq muddatli salohiyatiga asoslangan. Kompaniyaning P/E dinamikasini tahlil qilish orqali investor bozor qiymatining yillik sof foydaga nisbatini ko'rishi mumkin, bu esa kelajakdagi muvaffaqiyatlar haddan tashqari qimmat baholanganmi yoki biznesning qiymati past baholanganmi, shuni aniqlashga yordam beradi. Ushbu ko'rsatkich joriy kapitalizatsiyani haqiqiy moliyaviy natijalar bilan solishtirib, bozorning emitent kapitaliga bo'lgan ishonch darajasini aks ettiradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|TRML (Tourmaline) - Narx-foyda multiplikatori|PGEN (Precigen, Inc.) - Narx-foyda koeffitsiyenti|PHAR: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narxning foydaga nisbati UPB|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|IMNM (Immunome Bio) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|Biznesning o‘zini qoplash muddati Pieris Pharma PVLA|Savara Corp (SVRA) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Rigel Corp (RIGL)|Narxning foydaga nisbati AnaptysBio, Inc.|astriatx.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ENGN|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori JBIO (Aerovate Therapeutics)|P/E multiplikatori Aclaris Therapeutics, Inc ACRS|KYTX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - P/E multiplikatori|P/E multiplikatori Avalo Therapeutics Inc|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|P/E multiplikatori CLYM (Climb Bio)|Zura Bio Ltd (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|ADAG - P/E multiplikatori|IMA (ikenaoncology.com) - Narx-foyda koeffitsiyenti|STTK: Bozor narxining sof foydaga nisbati|EQ (Equillium Inc) - P/E multiplikatori|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori IMUX|Narx-foyda koeffitsiyenti atarabio.com ATRA|P/E multiplikatori IFRX (InflaRx)|P/E multiplikatori x4pharma.com XFOR|ACET - Narxning foydaga nisbati|CELU: Narxning foydaga nisbati|INmune Bio Corp (INMB) - Narxning foydaga nisbati|BRNS - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti KZR|Narx-foyda multiplikatori SABS (sabbiotherapeutics.com)|Narx-foyda koeffitsiyenti AKTX (Akari Therapeutics Plc)|Bozor narxining sof foydaga nisbati ENLV|Narxning foydaga nisbati Q32 Bio QTTB|GeoVax Corp - Narxning foydaga nisbati|Edesa Biotech, Inc. - P/E multiplikatori|IBIO: Narxning foydaga nisbati|carismatx.com (CARM) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati BOLT (Bolt Biotherapeutics, Inc.)|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|APVO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|Narxning foydaga nisbati GRI Bio GRI|Kompaniya qiymatining sof foydaga nisbati XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|Narx-foyda koeffitsiyenti CALI|AFMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ALLK|Biznesning o‘zini qoplash muddati hookipapharma.com|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA - Narxning foydaga nisbati|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
